164 related articles for article (PubMed ID: 37663943)
21. PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma.
Edge SD; Renard I; Pyne E; Li C; Moody H; Roy R; Beavis AW; Archibald SJ; Cawthorne CJ; Maher SG; Pires IM
Br J Radiol; 2021 Mar; 94(1119):20201191. PubMed ID: 33434085
[TBL] [Abstract][Full Text] [Related]
22. Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients.
Davern M; Donlon NE; O'Connell F; Gaughan C; O'Donovan C; Habash M; Sheppard AD; MacLean M; Dunne MR; Moore J; Temperley H; Conroy MJ; Butler C; Bhardwaj A; Ravi N; Donohoe CL; Reynolds JV; Lysaght J
Cancer Immunol Immunother; 2023 Jan; 72(1):55-71. PubMed ID: 35708739
[TBL] [Abstract][Full Text] [Related]
23. Autophagy facilitates the release of immunogenic signals following chemotherapy in 3D models of mesothelioma.
Follo C; Cheng Y; Richards WG; Bueno R; Broaddus VC
Mol Carcinog; 2019 Oct; 58(10):1754-1769. PubMed ID: 31215708
[TBL] [Abstract][Full Text] [Related]
24. Immunogenic Cell Death in Electroporation-Based Therapies Depends on Pulse Waveform Characteristics.
Polajžer T; Miklavčič D
Vaccines (Basel); 2023 May; 11(6):. PubMed ID: 37376425
[TBL] [Abstract][Full Text] [Related]
25. Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ
Elhassanny A; Escobedo R; Ladin D; Burns C; Van Dross R
Oncotarget; 2020 Dec; 11(52):4788-4802. PubMed ID: 33447347
[TBL] [Abstract][Full Text] [Related]
26. Immunogenic Cell Death Role in Urothelial Cancer Therapy.
Yadollahvandmiandoab R; Jalalizadeh M; Buosi K; Garcia-Perdomo HA; Reis LO
Curr Oncol; 2022 Sep; 29(9):6700-6713. PubMed ID: 36135095
[TBL] [Abstract][Full Text] [Related]
27. Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib.
Buckley AM; Dunne MR; Morrissey ME; Kennedy SA; Nolan A; Davern M; Foley EK; Clarke N; Lysaght J; Ravi N; O'Toole D; MacCarthy F; Reynolds JV; Kennedy BN; O'Sullivan J
Sci Rep; 2020 Jul; 10(1):12105. PubMed ID: 32694701
[TBL] [Abstract][Full Text] [Related]
28. The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines.
von Hofsten S; Paulsen MH; Magnussen SN; Ausbacher D; Kranz M; Bayer A; Strøm MB; Berge G
Sci Rep; 2022 Sep; 12(1):15586. PubMed ID: 36114339
[TBL] [Abstract][Full Text] [Related]
29. Proteomic signatures of radioresistance: Alteration of inflammation, angiogenesis and metabolism-related factors in radioresistant oesophageal adenocarcinoma.
Marcone S; Buckley A; Ryan CJ; McCabe M; Lynam-Lennon N; Matallanas D; O Sullivan J; Kennedy S
Cancer Treat Res Commun; 2021; 27():100376. PubMed ID: 33882379
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma.
Powell AGMT; Chin C; Coxon AH; Chalishazar A; Christian A; Roberts SA; Lewis WG
BJS Open; 2020 Jun; 4(3):416-423. PubMed ID: 32232963
[TBL] [Abstract][Full Text] [Related]
31. PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours.
Davern M; Fitzgerald MC; Buckley CE; Heeran AB; Donlon NE; McGrath J; O' Connell F; Deshpande MR; Hayes C; MacDonald J; Sheppard AD; Reynolds JV; Maher SG; Lynam-Lennon N; Murphy B; Lysaght J
Transl Oncol; 2022 May; 19():101381. PubMed ID: 35245832
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells.
Wang X; Ji J; Zhang H; Fan Z; Zhang L; Shi L; Zhou F; Chen WR; Wang H; Wang X
Oncotarget; 2015 Dec; 6(42):44688-702. PubMed ID: 26625309
[TBL] [Abstract][Full Text] [Related]
33. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
Aria H; Rezaei M
Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
[TBL] [Abstract][Full Text] [Related]
34. Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma.
O'Connell F; Mylod E; Donlon NE; Heeran AB; Butler C; Bhardwaj A; Ramjit S; Durand M; Lambe G; Tansey P; Welartne I; Sheahan KP; Yin X; Donohoe CL; Ravi N; Dunne MR; Brennan L; Reynolds JV; Roche HM; O'Sullivan J
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980567
[TBL] [Abstract][Full Text] [Related]
35. An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma.
Wu Y; Li K; Liang S; Lou X; Li Y; Xu D; Wu Y; Wang Y; Cui W
Respir Res; 2023 May; 24(1):142. PubMed ID: 37259066
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells.
Davern M; Donlon NE; Sheppard A; Connell FO; Hayes C; Bhardwaj A; Foley E; Toole DO; Lynam-Lennon N; Ravi N; Reynolds JV; Maher SG; Lysaght J
Transl Oncol; 2021 Jun; 14(6):101062. PubMed ID: 33765543
[TBL] [Abstract][Full Text] [Related]
37. Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma.
Buckley AM; Lynam-Lennon N; Kennedy SA; Dunne MR; Aird JJ; Foley EK; Clarke N; Ravi N; O'Toole D; Reynolds JV; Kennedy BN; O'Sullivan J
Oncotarget; 2018 Sep; 9(72):33634-33647. PubMed ID: 30263091
[TBL] [Abstract][Full Text] [Related]
38. Altered T Cell Migratory Capacity in the Progression from Barrett Oesophagus to Oesophageal Adenocarcinoma.
Kavanagh ME; Conroy MJ; Clarke NE; Gilmartin NT; Feighery R; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; O' Sullivan J; Lysaght J
Cancer Microenviron; 2019 Apr; 12(1):57-66. PubMed ID: 30834503
[TBL] [Abstract][Full Text] [Related]
39. Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker.
Birmpilis AI; Paschalis A; Mourkakis A; Christodoulou P; Kostopoulos IV; Antimissari E; Terzoudi G; Georgakilas AG; Armpilia C; Papageorgis P; Kastritis E; Terpos E; Dimopoulos MA; Kalbacher H; Livaniou E; Christodoulou MI; Tsitsilonis OE
Cells; 2022 Apr; 11(9):. PubMed ID: 35563721
[TBL] [Abstract][Full Text] [Related]
40. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer.
Fucikova J; Kasikova L; Truxova I; Laco J; Skapa P; Ryska A; Spisek R
Immunol Lett; 2018 Jan; 193():25-34. PubMed ID: 29175313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
